Manuyakorn A, Paulus R, Farrell J, Dawson NA, Tze S, Hines OJ, Reber H, Seligson DB, Horvath S, Kurdistani SK, Guha C & Dawson DW. “Cellular histone modification patterns predict prognosis and treatment response in resectable pancreatic adenocarcinoma: results from RTOG 9704,” J Clin Oncol. in press (2009).

Seligson DB, Horvath S, McBrian MA, Mah V, Yu H, Tze S, Wang Q, Chia D, Goodglick L and Kurdistani SK. “Global Levels of Histone Modifications Predict Prognosis in Different Cancers.” Am J Pathol., 174, 1619-1628 (2009).

Ferrari R, Berk AJ and Kurdistani SK. “Viral manipulation of the host epigenome for oncogenic transformation.” Nat Rev Genet., 10, 290-294 (2009).

Gekas C, Rhodes KE, Gereige LM, Helgadottir H, Ferrari R, Kurdistani SK, Montecino-Rodriguez E, Bassel-Duby R, Olson E, Krivtsov AV, Armstrong S, Orkin SH, Pellegrini M and Mikkola HK. “Mef2C is a lineage-restricted target of Scl/Tal1 and regulates megakaryopoiesis and B-cell homeostasis.” Blood, 113, 3461-3471 (2009).

McBrain MA and Kurdistani SK. “Histone modifications.” Encyclopedia of Cancer, 2nd edition, Springer (2009).

Ferrari R, Pellegrini M, Horwitz GA, Xie W, Berk AJ and Kurdistani SK. “Epigenetic reprogramming by adenovirus e1a.” Science, 321, 1086-1088 (2008).

Horwitz GA, Zhang K, McBrian MA, Grunstein M, Kurdistani SK and Berk AJ. “Adenovirus small e1a alters global patterns of histone modification.” Science, 321, 1084-1085 (2008).

Peng W, Togawa C, Zhang K and Kurdistani SK. “Regulators of cellular levels of histone acetylation in Saccharomyces cerevisiae.” Genetics, 179, 277-89 (2008).

Pham H, Ferrari R, Cokus SJ, Kurdistani SK and Pellegrini M. “Modeling the regulatory network of histone acetylation in Saccharomyces cerevisiae.” Mol Syst Biol., 153 (2007).

Kurdistani SK. “Histone modifications as markers of cancer prognosis: a cellular view.” Br J Cancer, 97, 1-5 (2007)

Kurdistani SK. “Epigenetic information in gene expression and cancer.” Henry Stewart Talks, electronic media (2006).

Seligson DB, Horvath S, Shi T, Yu H, Tze S, Grunstein M, and Kurdistani SK. “Global histone modification patterns predict risk of prostate cancer recurrence.” Nature, 435, 1262-1266 (2005).

Keogh MC, Kurdistani SK, Morris SA, Ahn SH, Podolny V, Collins SR, et al. “Cotranscriptional Set2 methylation of histone H3 lysine 36 recruits a repressive Rpd3 complex.” Cell, 123, 593-605 (2005)

Kurdistani SK, Tavazoie S, and Grunstein M. “Mapping global histone acetylation patterns to gene expression.” Cell, 117, 721-733 (2004).

Robyr D, Kurdistani SK, and Grunstein M. “Analysis of genomewide histone acetylation state and enzyme binding using DNA microarrays.” Methods Enzymol., 376, 289-304 (2004).

Kim K., Ongusaha PP, Hong YK, Kurdistani SK, Nakamura M, Lu KP, and Lee SW. “Function of Drg1/Rit42 in tumor suppressor p53-dependent mitotic spindle checkpoint.” J. Biol. Chem., 279, 38597-38602 (2004).

Millar CB, Kurdistani SK and Grunstein M. “Acetylation of yeast histone H4 lysine 16: A switch for protein interactions in heterochromatin and euchromatin.” Cold Spring Harb. Symp. Quant. Biol., 69, 1-8 (2004).

Kurdistani SK and Grunstein M. “In vivo protein-protein and protein-DNA crosslinking for genomewide binding microarray.” Methods, 31, 90-95 (2003).

Kurdistani SK and Grunstein M. “Histone acetylation and deacetylation in yeast.” Nat. Rev. Mol. Cell Biol., 4, 276-284 (2003).

Robyr D, Suka Y, Xenarios I, Kurdistani SK, Wang A, Suka N, and Grunstein M. “Microarray deacetylation maps determine genomewide functions for yeast histone deacetylases.” Cell, 17, 437-446 (2002).

Kurdistani SK, Robyr D, Tavazoie S, and Grunstein M. “Genomewide binding map of the Rpd3 histone deacetylase in Saccharomyces cerevisiae.” Nat. Genet., 31, 248-254 (2002).

Wang A, Kurdistani SK, and Grunstein M. “Requirement of Hos2 histone deacetylase for gene activity in yeast.” Science, 298, 1412-1414 (2002)

Reimer CL, Borras AM, Kurdistani SK, Garreau JR, Chung M, Aaronson SA, and Lee SW. “Altered regulation of cyclin G in human breast cancer and its specific localization at replication foci in response to DNA damage in p53+/+ cells.” J. Biol. Chem., 274, 11022-11026 (1999).

Kurdistani SK, Arizti P, Sugrue MM, Aaronson SA, and Lee SW. “Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage.” Cancer Res., 58, 4439-4444 (1998).

Kurdistani SK, Robbins TA, and Cram DJ. “Comparisons of activation energies for dimethyl sulfoxide rotations in the inner phase of seven carcerands.” Chem. Comm., 117, 1259-1260 (1995).

Kurdistani SK, Helgeson RC, and Cram DJ. “Stepwise shell closures provide hosts that expose or protect guests from outer phase reactants.” J. Am. Chem. Soc., 117, 1659-1660 (1995).